你以前也许未听说过:ipilimumab:与:nivolumab:两个药,不过这2种药物未来将会有效治疗皮肤癌。研究表明,上述两种药物联合使用能够清除22%黑色素瘤患者体内的肿瘤。然而,此前这两类药物一直是分开使用的,如今,科学家们通过联合用药起到了更佳的效果。在最近一项囊括142名患者的临床试验中,69%的患者在经过联合用药之后存活时间>2年,相比之下对照组只有 You may not have heard of it before: ipilimumab: And: nivolumab: Two drugs, but these two drugs will effectively treat skin cancer in the future. Research shows that the combination of these two drugs can clear the tumor in 22% of melanoma patients. However, these two types of drugs have been used separately until now, and scientists are now using the combination drug to achieve better results. In a recent clinical trial of 142 patients, 69% had a survival of> 2 years after co-administration, compared with only